- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our monthly e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Authors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- Colleen Lerro
- David Thomas
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Timothy Coetzee
- Tracy Cooley
Tags
BIO global food crisis Climate Change BIO Investor Forum renewable fuel standard Animal biotechnology Partnering ethanol greenhouse gas emissions Biofuel Technology Greenhouse Gas Emission indirect land use change Food and Fuel One-on-One's Food Plant biotechnology Benefits of biotech crops biotechnology agriculture
Author Archive: BIOtechNOW Editor
AUTM Website Helps Commercialize University Technologies
By Robin L. Rasor, CLP, RTTP, AUTM President As president of the Association of University Technology Managers (AUTM), I’m in a unique position of hearing from university technology managers who want more opportunity to interact with industry, and industry members who want to identify the latest breakthrough innovations. Industry investors and their academic licensing counterparts already come together for dealmaking at the AUTM Annual Meeting and at the BIO International Convention, but now we have Read More >
The BioGENEius Challenge: Prarthana Dalal
By Prarthana Dalal, 2011 International BioGENEius Challenge 1st Place Winner Project Title: Modeling of human non-deletional hereditary persistence of fetal hemoglobin (HPFH) conditions in β-globin locus transgenic mouse models: The -175 (T to C) and -195 (C to G) A-gamma globin gene point mutations Project Description: My project was focused on hemoglobingenetics and how sequence changes can effect fetal hemoglobin production in mouse models, which can be used to understand treatment mechanisms for sickle cell Read More >
The BioGENEius Challenge: Priyen Patel
By Priyen Patel, 2011 U.S. National BioGENEius Media Award Winner Project Title: Over-the-Counter and In Your Water? The Most Effective Filtration of Pharmaceuticals Project Description: Research shows minute concentrations of drugs in 51 million Americans’ water, leading to tumors and reproductive problems in fish and slowing the growth of kidney cells in humans. I focused on filtering ibuprofen and acetaminophen and my results are: the water distiller (100% effective), the activated carbon filter and ion Read More >
BIO CEO Company Snapshot: ImmunoGen, Inc.
In the latest Company Snapshot for the 2012 BIO CEO & Investor Conference in New York City, we’re profiling ImmunoGen, Inc. which will be presenting at the event. We spoke with ImmunoGen, Inc. CEO Daniel Junius and he outlined his organization’s priorities and challenges as well as how his company differentiates themselves from the competition. Company Snapshot What are the short-term and long-term priorities for your company? Our highest priority today is building and advancing our pipeline Read More >
Is the Polio Vaccine an Anti-Patent Success Story?
By Hans Sauer, Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization Question from a Reader: Heather: Whether Jonas Salk believed in patenting research or not isn’t important, at least not to me. What I do find important, and hadn’t realized until reading this article, is that the polio vaccine was extremely successful despite the fact that it wasn’t patented. That sounds like an interesting story because it goes against the current dogma of ‘we won’t Read More >
